Doximity (DOCS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Aug, 2026Market leadership and network reach
Over 85% of U.S. physicians are members, with more than 800,000 unique active providers using workflow tools as of Q1 2026.
All top 20 U.S. hospitals and pharmaceutical manufacturers are clients.
Net revenue retention rate stands at 107% for the trailing twelve months ending June 2026.
Product innovation and AI integration
Offers a comprehensive suite of HIPAA-compliant tools: telehealth, digital fax, e-signature, secure messaging, scheduling, and AI workflow solutions.
Acquired Pathway Medical for $63 million to enhance AI-powered clinical decision support.
Clinical AI suite, including Doximity Ask, outperforms leading models in safety and accuracy benchmarks.
Engagement and commercial solutions
Over 1 million unique quarterly active prescribers engage with the platform.
Engagement is strong throughout the day across newsfeed and workflow tools.
Marketing solutions deliver high ROI: 17:1 for health systems and ~10:1 for pharma clients.
Latest events from Doximity
- Revenue up 7% to $157M, net income down, strong AI adoption, over $90M in share repurchases.DOCS
Q1 20277 Aug 2026 - Proxy covers director elections, auditor ratification, and executive pay, with strong governance and ESG focus.DOCS
Proxy filing15 Jul 2026 - Virtual meeting to vote on directors, auditor, and executive pay, with board support for all.DOCS
Proxy filing15 Jul 2026 - 20% revenue growth, record margins, and strong AI-driven engagement set up for cautious FY26.DOCS
Q4 20259 Jul 2026 - Q3 revenue up 25% with margin expansion, record engagement, and ongoing share repurchases.DOCS
Q3 20258 Jul 2026 - Record free cash flow, strong AI adoption, and 13% revenue growth set up modest FY27 outlook.DOCS
Q4 202620 May 2026 - Delivers AI-powered workflow tools to 85%+ of U.S. physicians, achieving 22% revenue CAGR.DOCS
Investor presentation13 May 2026 - Revenue up 10% to $185.1M, strong margins, AI acquisition, and $500M buyback authorized.DOCS
Q3 202616 Apr 2026 - AI-powered platform with 85% physician reach, rapid revenue growth, and strong market penetration.DOCS
Investor presentation25 Feb 2026